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Objective
The authors determined whether microscopically positive surgical margins are detrimental to the
outcome of early stage breast cancer patients treated with conservation surgery and radiation
therapy.
Summary Background Data
The optimal extent of breast surgery required for patients treated with conservation surgery and
radiation therapy has not been established. To achieve breast preservation with good cosmesis,
it is desirable to resect as little normal tissue as possible. However, it is critical that the resection
does not leave behind a tumor burden that cannot be adequately managed by moderate doses
of radiation. It is not known whether microscopically positive surgical margins are detrimental to
patient outcome.
Methods
The records of 259 consecutive women (262 breasts) treated with local excision (complete
removal of gross tumor with a margin) and axillary dissection followed by radiation therapy for
clinical stage and 11 infiltrating ductal breast cancer at Duke University Medical Center and the
University of North Carolina between 1983 and 1988 were reviewed. Surgical margins were
considered positive if tumor extended to the inked margins; otherwise the margins were
considered negative. Margins that could not be determined, either because the original pathology
report did not comment on margins, or because the original specimen had not been inked were
called indeterminate.
Results
Of the 262 tumors, 32 (12%) had positive margins, 132 (50%) had negative margins, and the
remaining 98 (38%) had indeterminate margins. There were 11 (4%) local failures; 3/32 (9%)
from the positive margin group, 2/132 (1.5%) from the negative margin group, and 6/98 (6%)
from the indeterminate group. The actuarial local failure rates at 5 years were 10%, 2%, and
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10%, respectively, p = 0.014 positive vs. negative, p = 0.08 positive vs. indeterminate (log rank
test). Margin status had no impact on survival or freedom from distant metastasis; 63 patients
who originally had positive or indeterminate margins were re-excised. Two of 7 with positive
margins after re-excision versus 1/56 rendered margin negative had a local recurrence.
Conclusions
The authors recommend re-excision for patients with positive margins because of improved local
control of those rendered margin negative and identification of those patients at high risk for
local failure (those who remain positive after re-excision). Because margin status impacts on local
control, tumor margins after conservation surgery should be accurately determined in all patients.
Definitive radiation after conservation surgery for
early-stage breast cancer is an established alternative to
mastectomy for a defined patient population. The Na-
tional Institutes of Health Consensus Conference in Jan-
uary 1991 recommended breast conservation treatment
as the preferred method of primary therapy for "... the
majority ofwomen with stage I and II breast cancer..."'
Breast conservation surgery has been defined as com-
plete excision of the primary tumor and adjacent breast
tissue with or without axillary dissection. However, the
optimal extent of the breast surgery required for patients
treated with definitive irradiation has not been estab-
lished. Since the rationale for breast conservation sur-
gery is breast preservation with good cosmesis, it is desir-
able to resect as little normal tissue as possible. On the
other hand it is critical that the resection does not leave
behind a tumor burden that cannot be adequately man-
aged by moderate doses of radiation. It is not known
whether microscopically positive surgical margins are
detrimental to patient outcome; the literature is contra-
dictory on this subject.2-'2 To derive further informa-
tion, we undertook a retrospective review of all clinical
stage I and II patients treated at Duke University Medi-
cal Center (DUMC) and the University of North Caro-
lina Hospitals (UNCH) with conservative surgery and
radiation therapy.
MATERIALS AND METHODS
The records of 259 consecutive women (262 breasts)
treated with local excision (complete removal of gross
tumor with a margin) and axillary dissection followed by
radiation therapy for invasive breast carcinoma at Duke
University Medical Center and the University of North
Carolina between 1983-1988 were evaluated. This repre-
sents all patients with clinical stage I and II infiltrating
ductal breast cancer treated with conservation surgery
and radiation therapy at the two institutions over this
time period. Patients whose surgery was performed else-
where, but who were irradiated at either ofthe two medi-
cal centers (or affiliates) were included in the analysis.
A pathologic review ofthe original tumor slides in 137
of the 262 breasts was undertaken by a pathologist in
each institution (RR and AT). Slides were randomly ex-
changed and cross-read by pathologists from both insti-
tutions. In the few cases in which there was disagreement
between the pathologists, the findings were discussed
and a consensus was reached. On a few occasions, surgi-
cal specimens were recut for further analysis ofan inked
margin. Non-inked specimens available for review were
not recut since these were, by definition, indeterminate
(see below).
The practice of inking surgical specimens for margin
analysis varied over the years of the study. Few speci-
mens from outside institutions were routinely inked. At
both DUMC and UNCH, specimens were not routinely
inked until the later years of the study. Margins were
considered positive iftumor extended to the inked mar-
gin; otherwise the margins were considered negative.
The original pathology report was considered definitive
for the 125 cases in which the slides were not available
for review. If the patient had undergone a re-excision of
the primary site, the final pathology report was the one
used to determine marginal status. For example, if the
original resection margin was pathologically positive and
no tumor was identified in the re-excision specimen, the
patient was considered to have negative margins. Mar-
gins that could not be determined, either because the
original pathology report did not comment on margins,
or because the original specimen had not been inked
were called indeterminate.
Clinical data collected included age, T and N stage
(clinical and pathological), radiation dose to the breast
and tumor bed, adjuvant therapy received, hormonal re-
ceptor status, presence or absence of extensive intraduc-
tal carcinoma (EIC) in the lumpectomy specimen and
patient outcome with respect to local control, survival,
freedom from distant disease, and disease free survival.
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EIC was defined according to the criteria of Schnitt.'3
Local failure only was defined as a recurrence in the
treated breast without regional or distant metastases. Re-
gional failure was defined as failure in the ipsilateral axil-
lary, infraclavicular, supraclavicular, or internal mam-
marv nodes without distant metastases. Local and re-
gional failure was defined as simultaneous failure in the
breast and regional nodes without distant metastases. All
other sites of failure were considered distant metastases.
New cancers arising in the opposite breast were consid-
ered second primaries, not recurrences.
All patients were treated with external beam radiation
and most had boosts with either electrons or interstitial
'92Ir. Axillary nodes were not irradiated after axillary dis-
section unless there was extensive axillary nodal involve-
ment. Treatment of internal mammary and supraclavic-
ular nodes varied by institution and also with time, elec-
tive treatment of internal mammary and supraclavicular
nodes being less common at UNCH than at DUMC.
These draining nodal groups were treated only in pa-
tients whose axillary status was unknown or positive.
Total breast doses ranged from 43.2 to 50.4 Gy except
for two patients who received 30 and 42 Gy. Total tumor
bed doses ranged from 42 to 71 Gy. (Fig. 1, Table 1). All
treatments were given with megavoltage energies with
daily fractions ranging from 1.8 to 2.0 Gy/day 5 days per
week.
Adjuvant tlherapyv during the years of this study,
whether cytotoxic or hormonal, was usually reserved for
node positive patients.
Patients were involved in follow-up by both their sur-
geon and radiation oncologist at 3-month intervals for
the first 2 years, and semiannually thereafter. Mammo-
grams were obtained at least once per year after treat-
ment. Other radiographic or laboratory tests were ob-
tained onlv as needed. This schedule was used by both
Institutions.
Survival and local control curves were estimated by
the method of Kaplan and Meier.'4 The log-rank test'5
was used to compare survival distributions.
To detect significant prognostic factors, a univariate
Cox regression analysis16 was performed to study the
predictive information available in each variable acting
independently. This was followed by a multivariate re-
gression analysis performed in a step-wise manner enter-
ing initially the most significant prognostic factors.
RESULTS
Of excisions in 262 breasts, 32 (12C/c) had positive mar-
gins, 132 (50%(c) had negative margins, and the remaining
98 (38%) had indeterminate margins. Median follow-up
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Figure 1. Histogram of total tumor bed dose (breast dose plus implant).
Median dose was 62 Gy.
failures overall in the breast; 3/32 (9%Y.>) from the positive
margin group, 2/132 (1.5%YO) from the negative margin
group, and 6/98 (6%7.) from the indeterminate group. The
actuarial local failure rates at 5 years were 10%, 2%, and
10'%'. respectively (p = 0.014 positive vs. negative, p
0.08 positive vs. indeterminate, log-rank test) (Fig. 2).
On pathologic review, approximately 20% of the cases
originally classified as having positive or negative mar-
gins had their margin status reversed (2/7 positive to neg-
ative, 7/36 negative to positive). Of the group previously
called indeterminate, it was possible to assign a margin
status to 50/94 (35 negative, 15 positive). Of the 125
cases not available for review, margins were positive in 3
(2%), negative in 53 (42%(.) and indeterminate in 69 (56%).
The characteristics of the positive, negative, and inde-
terminate margin patients are compared in Table 1. The
positive and negative margin patients were similar in all
respects. The indeterminate margin group had a higher
percentage of positive nodes, and a lower percentage of
an extensive intraductal component (EIC) to the tumor
than the other two groups.
Of special interest are the 63 patients who originally
had positive or indeterminate margins who were re-ex-
cised. Seven re-excisions had persistently positive mar-
gins (+ -+), the remaining 56 were negative (+ -)
The local failure rate in the + + group was 2/7 (28%)
versus 1/56 (2%) in the + - group. The local failure of
the 76 patients with negative margins at first excision
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Positive Negative Indeterminate
Characteristic Margins Margins Margins
Number 32 132 98
Age (years)
Median 58.5 54 57
Range 35-76 30-91 28-84
T-stage (clinical)
1% (1)
To 6% (2) 5% (7) 3% (3)
T, 72% (23) 65% (85) 68% (67)
T2 22% (7) 30% (40) 28% (27)
N-stage (path)
N-stage (path) 12% (4) 8% (10) 26% (25)
No 72% (23) 75% (99) 50% (49)
N+ 16% (5) 17% (23) 24% (24)
Stage (path)
Stage X 12% (4) 6% (8) 18% (18)
Stage 72% (23) 72% (95) 51% (50)
Stage 11 16% (5) 22% (29) 31% (30)
Tumor dose (Gy)
Median 61.7 62 63.8
Range 47-67.2 46-71 42-70
Adjuvant therapy
Chemotherapy 12% (4) 23% (30) 29% (28)
Hormonal therapy 16% (5) 12% (16) 11% (11)
Receptor Status
ER+ 18%(6) 21% (27) 21% (21)
ER- 41% (13) 40% (53) 25% (24)
ER unknown 41% (13) 39% (52) 54% (53)
PR+ 9% (3) 15% (20) 12% (12)
PR- 50% (16) 41% (54) 29% (28)
PR unknown 41% (13) 44% (58) 59% (58)
EIC
Present 16% (5) 11% (14) 6% (6)
Absent 31% (10) 47% (62) 57% (56)
Unknown 53% (17) 42% (56) 37% (36)
Follow up (months)
Median 43 44 45
Range 4-76 4-91 7-92
was 1/76 (1.5%), no different than the patients rendered
negative with re-excision.
The presence ofEIC was found to be a significant pre-
dictor of local failure with a univariate analysis, but not
when controlling for marginal status using a multivariate
analysis.
There was no difference between those patients who
failed locally and those who did not, with respect to use
of systemic therapy, tumor size, nodal status, and radia-
tion dose or other factors listed in Table 1.
After accounting for the difference in nodal status be-
tween the groups, margin status had no significant im-
pact on survival, disease-free survival, or freedom from
distant metastases. The results of the multivariate analy-
sis indicated that only nodal status affected survival.
DISCUSSION
Many retrospective studies involving thousands of pa-
tients with Stage I or II breast cancer have demonstrated
that conservation surgery and radiation therapy produce
disease-free survival rates comparable to classical or
modified radical mastectomy. 17-26 Ten-year actuarial lo-
cal control rates are 80%-90%.27 This is similar to rates
recorded from surgical series.27-29 These results have
been confirmed by at least six prospective randomized
trials.30'3'
Older studies have shown the importance of excising
the primary tumor before definitive radiation therapy.
For example, Calle32 reported a local failure rate of 59%
in 384 patients treated exclusively with radiation after
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Local Control for Patients with Positive,
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Figure 2. Local control versus marginal status. The negative margin pa-
tients did statistically better than the positive margin patients (p = 0.014,
log rank test).
incisional biopsy. Amalric et al.'8 reported a local-re-
gional failure rate of 38% in their series. Both studies
achieved superior local-regional control when a local ex-
cision was performed before irradiation.
Although leaving gross residual tumor before irradia-
tion is detrimental to the outcome, much less is known
about the need for obtaining microscopically negative
margins. The data are conflicting, with five series show-
ing no increase in breast recurrence with positive mar-
gins, 4,6,7 and five showing a higher recurrence rate if
margins are positive58'o 12 (Table 2). In the largest study,
Solin2 found that local failure, relapse-free survival, and
survival rates were not influenced by marginal status.
Nevertheless he recommends re-excision, if possible, to
achieve histologically negative margins. The rationale
for this recommendation is unclear.
We had 20% reversal of margin status on review.
Given that historically no standards were established for
classifying breast tumor excisions as "positive" nor "neg-
ative" it is not surprising that 1/5 of the tumor margins
were reclassified. We can find no published reports with
which to compare our reclassification rate. It is unfortu-
nate that 125 cases were not available for review. How-
ever, an analysis ofour data using only the original mar-
gin classification did not yield different results. Our expe-
rience suggests that more consistent methods of
determining margin status are needed.
Our high rate of local recurrence in patients who had
positive margins after re-excision (2/7) suggests that
these patients might best be treated with mastectomy.
However, patients with initially positive (or indetermi-
nate) excision margins who were rendered margin nega-
tive did well (1/56 local failures). It is not clear whether
the act of re-excision in these patients is therapeutic or
diagnostic, in the sense that it identifies patients at ex-
traordinarily high risk for local failure with conservative
surgery and radiation. However, we believe that the
identification of these patients, alone, is justification for
re-excising positive margin patients.
Perhaps the most well-known prognostic factor for
predicting local failure after conservative surgery and ra-
diation is the presence of extensive intraductal carci-
noma (EIC) as defined by Schnitt.'3 The data are con-
flicting. For example, Fisher33 found no correlation be-
tween EIC and local recurrence in his review of the
NSABP trial Protocol 6.
In our study both EIC and marginal status were found
to be prognostic for local failure with a univariate analy-
sis. However, the importance of EIC was eliminated
when a multivariate analysis was done. Unfortunately
only 5 of 11 studies in the literature that reported on the
effects of positive margins controlled for the presence of
EIC with appropriate multivariate analyses.5'6'8'0 Like
us, Zafrani9 found that marginal status was important,
but EIC was not. In the other four studies, three did not
ink their specimens5 9 10 and one adopted an unusual defi-
nition of "positive margins."8 Thus the studies in the
literature differ in their definitions of positive margins
and whether a multivariate analysis was used. A stan-
dard definition for what constitutes a positive margin
would be most helpful. Our use of the term "positive
margin" means cancer cells at the inked edge and is in
accordance with the NSABP usage. Tumor 1 mm away
from the edge is considered "negative." When the lack of
good pathologic data (non-inked specimens) and varia-
tion in boost radiation dose are also considered, it is not
surprising that studies arrive at conflicting conclusions.
The goal of conservation surgery and radiation is to
provide the patient with a treatment as effective as mas-
tectomy with the added benefit ofgood cosmesis. One of
the factors that has been shown to adversely affect the
cosmetic result is the amount of breast tissue re-
moved.34'35 Thus, the amount of breast tissue removed
should be limited to optimize cosmesis.
On the other hand, cosmesis should not be empha-
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Multivariate
Study Margins EIC Analysis? Other Factors Comments
Solin2 No N/S No N/S Authors still recommend re-excision.
Clarke3 No N/S No Histologic grade, time between Only presence or absence of DCIS
biopsy and RT, and breast considered, not extent.
radiation dose
Schmidt- No No No N/S Positive margins defined as <2
Ullrich4 mm. Reexcised patients still
considered positive.
Kurtz5 Yes Yes Yes Major lymphocytic reaction and Specimens not inked.
histologic grade
Bartelink6 No Yes Yes Age All patients with EIC and recurrence
had positive or doubtful margins
Hunig7 No N/A No N/A
Ryoo8 Yes, but only if No Yes Age, ER negative Positive margins defined as < 5
no boost mm.
Zafrani9 Yes No Yes Lymphatic invasion. Specimens not inked. Definition of
EIC more restrictive than Schnift
Fourquet'° Yes No Yes Age, endolymphatic extension of Specimens not inked
tumor
Pezner"' Unclear N/S No N/S Difference between negative
margin with no boost, and
unknown margin patients only.
Hallahan12 Probably yes N/S No N/S P-values not given.
Present study Yes No Yes None
The evidence to date suggests that an isolated local recur-
rence in the breast does not adversely influence patient
survival,3'5"'0 but with longer follow-up, differences may
become apparent. Furthermore, local relapse usually re-
quires that the patient undergo mastectomy. On a num-
ber of grounds, it is desirable to minimize the risk of
breast recurrence. Re-excision of positive or indetermi-
nate margin patients appears to be helpful in this regard,
according to our data.
In conclusion, we recommend re-excision for patients
undergoing breast conservation therapy in whom the
original excisional margins are positive or indetermi-
nate. Local control may be improved ifnegative margins
can be obtained and a cohort ofpatients at increased risk
for local failure (those with positive margins on re-exci-
sion) can be identified. Since, local failure carries at least
a theoretical risk of increasing the chance of distant me-
tastases, care should be taken by surgeons and patholo-
gists to process lumpectomy specimens appropriately to
obtain the necessary information concerning margins.
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